Nizatidine API

Name	Nizatidine
Chinese name	尼扎替丁
Cas Number	76963-41-2
Source	India
Qualifications	USDMF/-/-/-/-

Nizatidine is the third generation of powerful competitive H2 receptor blocker launched by Eli Lilly of the United States. It has higher efficacy and fewer adverse reactions after cimetidine and ranitidine. Ulcer disease has more competitive advantages. Nizatidine acts on gastric acid secreting cells, blocks the formation of gastric acid and can reduce basic gastric acid. It can also inhibit gastric acid secretion caused by food and chemical stimulation, such as gastrin and acetylcholine. Nizatidine can significantly inhibit basic gastric acid and night gastric acid secretion, and inhibit gastric acid secretion caused by pentagastrin, caffeine and food stimulation. The effect is 4.8 to 17.8 times that of cimetidine, which is 2 times that of ranitidine. Times. Nizatidine is highly selective, almost not metabolized in the liver, and does not affect the activity of liver drug enzymes. Compared with cimetidine, ranitidine, and famotidine, its adverse reactions are the lightest.

Hot Tags: nizatidine api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Escitalopram Oxalate API, Bivalrudine API, Aprepitant Aprepitant API, Idebenone API, Rasagiline Mesylate API, Pazopanib Hydrochloride Pazopanib API

• Previous: Drotaverine Hydrochloride API
• Next: Avibactam Sodium API